HomeHealthcare and Life Sciences Europe Advanced Therapy Medicinal Products Market

Europe Advanced Therapy Medicinal Products Market Size, Share, Growth, and Industry Analysis, Type (Gene Therapy, Cell Therapy, Tissue Engineered Products), Application (Oncology, Rare Diseases, Orthopedics), Regional Insights and Forecast to 2034

Report Code: SMI1973PUB | Last Updated : 21 July, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : Europe | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Europe Advanced Therapy Medicinal Products Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Europe Advanced Therapy Medicinal Products Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Europe Advanced Therapy Medicinal Products Market, Type
    1. Introduction
      1. Market Size and Forecast, Type
    2. Gene Therapy
      1. Market Size and Forecast, By Region
    3. Cell Therapy
      1. Market Size and Forecast, By Region
    4. Tissue Engineered Products
      1. Market Size and Forecast, By Region
  10. Europe Advanced Therapy Medicinal Products Market, Application
    1. Introduction
      1. Market Size and Forecast, Application
    2. Oncology
      1. Market Size and Forecast, By Region
    3. Rare Diseases
      1. Market Size and Forecast, By Region
    4. Orthopedics
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. Europe
      1. Market Size and Forecast
        1. Type
          1. Gene Therapy
            1. Cell Therapy
              1. Tissue Engineered Products
              2. Application
                1. Oncology
                  1. Rare Diseases
                    1. Orthopedics
                  2. U.K.
                    1. Type
                      1. Gene Therapy
                        1. Cell Therapy
                          1. Tissue Engineered Products
                          2. Application
                            1. Oncology
                              1. Rare Diseases
                                1. Orthopedics
                              2. Germany
                              3. France
                              4. Spain
                              5. Italy
                              6. Russia
                              7. Nordic
                              8. Benelux
                              9. Rest of Europe
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. Europe Advanced Therapy Medicinal Products Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. Novartis AG
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. Gilead Sciences Inc.
                            3. Roche Holding AG
                            4. Sanofi SA
                            5. Bristol-Myers Squibb
                            6. Bluebird Bio
                            7. Orchard Therapeutics
                            8. Takeda Pharmaceutical
                            9. GlaxoSmithKline
                            10. Pfizer Inc.
                            11. Amgen Inc.
                            12. AstraZeneca PLC
                            13. BioNTech SE